Print this page    •   Back to Web version of article

CRIA Update
Table of Contents, Fall 1998

About this Issue

This issue of CRIA Update is devoted to current controversies in HIV treatment. Dr. Carl Fichtenbaum of Washington University has contributed a timely, state-of-the-art review of the issues of stopping prophylaxis and treatment of opportunistic infections in persons on highly active antiretroviral therapy. Tim Horn, a regular contributing writer, has summarized some of the controversies surrounding drug failure and salvage therapy. In a separate article, Tim addresses the current thinking on immune reconstitution and immune-based therapies. Jill Cadman updates us on the new issues surrounding perinatal transmission of HIV, and the controversial topic of post-exposure prophylaxis is detailed in a balanced article by Mike Barr. To start, CRIA's Medical Director highlights some of the key issues surrounding strategies of antiretroviral therapy.


CRIA co-sponsors monthly educational forums on AIDS research and treatment issues. Upcoming forums:

Wednesday, October 14th
New Drugs in Development

Wednesday, November 11th
The Immune System and Long-Term Survival

Wednesday, December 9th
Pediatric / Adolescent Update

The forums are held at 7PM in the Cronin Auditorium, 10th Floor of St. Vincent's Hospital at 11th Street and 7th Avenue, Manhattan.

This article was provided by AIDS Community Research Initiative of America. It is a part of the publication CRIA Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.